Eicosapentaenoic acid upregulates VEGF-A through both GPR120 and PPARγ mediated pathways in 3T3-L1 adipocytes

Molecular and Cellular Endocrinology

Volumn 406, Issue , 2015, Pages 10-18

  Hasan, Arif U ^a   Ohmori, Koji ^a   Konishi, Kumi ^a   Igarashi, Junsuke ^a   Hashimoto, Takeshi ^a   Kamitori, Kazuyo ^a   Yamaguchi, Fuminori ^a   Tsukamoto, Ikuko ^a   Uyama, Toru ^a   Ishihara, Yasuhiro ^a   Noma, Takahisa ^a   Tokuda, Masaaki ^a   Kohno, Masakazu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Cytokines; Diabetes; G proteins; Obesity; Protein kinases MAP kinase; 3 fatty acids

Indexed keywords

G PROTEIN COUPLED RECEPTOR 120; ICOSAPENTAENOIC ACID; LACTATE DEHYDROGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; VASCULOTROPIN A; G PROTEIN COUPLED RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; O3FAR1 PROTEIN, MOUSE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BINDING; PROTEIN KINASE C;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME ACTIVITY; FATTY ACID ANALYSIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION SITE; UPREGULATION; 3T3 CELL LINE; ANIMAL; BIOLOGICAL MODEL; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; METABOLISM; MOUSE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; EICOSAPENTAENOIC ACID; HEK293 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MODELS, BIOLOGICAL; PHOSPHATIDYLINOSITOL 3-KINASES; PPAR GAMMA; PROTEIN BINDING; PROTEIN KINASE C; RECEPTORS, G-PROTEIN-COUPLED; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84923322729     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.02.012     Document Type: Article

References (56)

1. Ahmadian M., Suh J.M., Hah N., Liddle C., Atkins A.R., Downes M., et al. PPARγ signaling and metabolism: the good, the bad and the future. Nat. Med 2013, 19:557-566.
2. Allred C.D., Talbert D.R., Southard R.C., Wang X., Kilgore M.W. PPARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells. J. Nutr 2008, 138:250-256.
3. Arany Z., Foo S.Y., Ma Y., Ruas J.L., Bommi-Reddy A., Girnun G., et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 2008, 451:1008-1012.
4. Arcondéguy T., Lacazette E., Millevoi S., Prats H., Touriol C. VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level. Nucleic Acids Res 2013, 41:7997-8010.
5. Bays H.E. Adiposopathy is "sick fat" a cardiovascular disease?. J. Am. Coll. Cardiol 2011, 57:2461-2473.
6. Calder P.C. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. Br. J. Clin. Pharmacol 2013, 75:645-662.
7. Chintalgattu V., Harris G.S., Akula S.M., Katwa L.C. PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. Cardiovasc. Res 2007, 74:140-150.
8. Edwards I.J., O'Flaherty J.T. Omega-3 fatty acids and PPARgamma in cancer. PPAR Res 2008, 2008:358052.
9. Elias I., Franckhauser S., Ferré T., Vilà L., Tafuro S., Muñoz S., et al. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance. Diabetes 2012, 61:1801-1813.
10. Emoto M., Anno T., Sato Y., Tanabe K., Okuya S., Tanizawa Y., et al. Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes. Diabetes 2001, 50:1166-1170.
11. Evans R.M., Barish G.D., Wang Y.X. PPARs and the complex journey to obesity. Nat. Med 2004, 10:355-361.
12. Fan W., Imamura T., Sonoda N., Sears D.D., Patsouris D., Kim J.J., et al. FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes. J. Biol. Chem 2009, 284:12188-12197.
13. Fernández-Galilea M., Pérez-Matute P., Prieto-Hontoria P.L., Martinez J.A., Moreno-Aliaga M.J. Effects of lipoic acid on lipolysis in 3T3-L1 adipocytes. J. Lipid Res 2012, 53:2296-2306.
14. Flachs P., Horakova O., Brauner P., Rossmeisl M., Pecina P., Franssen-van Hal N., et al. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 2005, 48:2365-2375.
15. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol 1996, 16:4604-4613.
16. Gardner A.M., Olah M.E. Distinct protein kinase C isoforms mediate regulation of vascular endothelial growth factor expression by A2A adenosine receptor activation and phorbol esters in pheochromocytoma PC12 cells. J. Biol. Chem 2003, 278:15421-15428.
17. González-Périz A., Horrillo R., Ferré N., Gronert K., Dong B., Morán-Salvador E., et al. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 2009, 23:1946-1957.
18. Gotoh C., Hong Y.H., Iga T., Hishikawa D., Suzuki Y., Song S.H., et al. The regulation of adipogenesis through GPR120. Biochem. Biophys. Res. Commun 2007, 354:591-597.
19. Gschwendt M., Dieterich S., Rennecke J., Kittstein W., Mueller H.J., Johannes F.J. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett 1996, 392:77-80.
20. Halberg N., Khan T., Trujillo M.E., Wernstedt-Asterholm I., Attie A.D., Sherwani S., et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol. Cell. Biol 2009, 29:4467-4483.
21. Hasan A.U., Ohmori K., Hashimoto T., Kamitori K., Hirata Y., Ishihara Y., et al. Pioglitazone promotes preadipocyte proliferation by downregulating p16(Ink4a). Biochem. Biophys. Res. Commun 2011, 411:375-380.
22. Hasan A.U., Ohmori K., Hashimoto T., Kamitori K., Yamaguchi F., Ishihara Y., et al. Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity. Hypertens. Res 2014, 37:621-628.
23. Heinemeyer T., Wingender E., Reuter I., Hermjakob H., Kel A.E., Kel O.V., et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998, 26:362-367.
24. Ichimura A., Hirasawa A., Poulain-Godefroy O., Bonnefond A., Hara T., Yengo L., et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 2012, 483:350-354.
25. Kalupahana N.S., Claycombe K., Newman S.J., Stewart T., Siriwardhana N., Matthan N., et al. Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J. Nutr 2010, 140:1915-1922.
26. Kalupahana N.S., Claycombe K.J., Moustaid-Moussa N. Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights. Adv. Nutr 2011, 2:304-316.
27. Kim H.K., Della-Fera M., Lin J., Baile C.A. Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. J. Nutr 2006, 136:2965-2969.
28. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:4318-4323.
29. Kosteli A., Sugaru E., Haemmerle G., Martin J.F., Lei J., Zechner R., et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J. Clin. Invest 2010, 120:3466-3479.
30. Lazar M.A. How obesity causes diabetes: not a tall tale. Science 2005, 307:373-375.
31. Lee M.S., Kwun I.S., Kim Y. Eicosapentaenoic acid increases lipolysis through up-regulation of the lipolytic gene expression and down-regulation of the adipogenic gene expression in 3T3-L1 adipocytes. Genes Nutr 2008, 2:327-330.
32. Lefterova M.I., Zhang Y., Steger D.J., Schupp M., Schug J., Cristancho A., et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 2008, 22:2941-2952.
33. Lehrke M., Lazar M.A. The many faces of PPARgamma. Cell 2005, 123:993-999.
34. Nelson J.D., Denisenko O., Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc 2006, 1:179-185.
35. Neschen S., Morino K., Rossbacher J.C., Pongratz R.L., Cline G.W., Sono S., et al. Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. Diabetes 2006, 55:924-928.
36. Oh D.Y., Olefsky J.M. Omega 3 fatty acids and GPR120. Cell Metab 2012, 15:564-565.
37. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.
38. Oh D.Y., Walenta E., Akiyama T.E., Lagakos W.S., Lackey D., Pessentheiner A.R., et al. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat. Med 2014, 20:942-947.
39. Pagès G., Pouysségur J. Transcriptional regulation of the Vascular Endothelial Growth Factor gene-a concert of activating factors. Cardiovasc. Res 2005, 65:564-573.
40. Peeters L.L., Vigne J.L., Tee M.K., Zhao D., Waite L.L., Taylor R.N. PPAR gamma represses VEGF expression in human endometrial cells: implications for uterine angiogenesis. Angiogenesis 2005, 8:373-379.
41. Prostek A., Gajewska M., Kamola D., Bałasińska B. The influence of EPA and DHA on markers of inflammation in 3T3-L1 cells at different stages of cellular maturation. Lipids Health Dis 2014, 13:3.
42. Rasband W.S. ImageJ 1997, National Institutes of Health, Maryland, US.
43. Regazzetti C., Bost F., Le Marchand-Brustel Y., Tanti J.F., Giorgetti-Peraldi S. Insulin induces REDD1 expression through hypoxia-inducible factor 1 activation in adipocytes. J. Biol. Chem 2010, 285:5157-5164.
44. Ricote M., Glass C.K. PPARs and molecular mechanisms of transrepression. Biochim. Biophys. Acta 2007, 1771:926-935.
45. Rodriguez-Pacheco F., Garcia-Serrano S., Garcia-Escobar E., Gutierrez-Repiso C., Garcia-Arnes J., Valdes S., et al. Effects of obesity/fatty acids on the expression of GPR120. Mol. Nutr. Food Res 2014, 58:1852-1860.
46. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
47. Storlien L.H., Kraegen E.W., Chisholm D.J., Ford G.L., Bruce D.G., Pascoe W.S. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987, 237:885-888.
48. Sun K., Kusminski C.M., Scherer P.E. Adipose tissue remodeling and obesity. J. Clin. Invest 2011, 121:2094-2101.
49. Sun K., Wernstedt Asterholm I., Kusminski C.M., Bueno A.C., Wang Z.V., Pollard J.W., et al. Dichotomous effects of VEGF-A on adipose tissue dysfunction. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:5874-5879.
50. Talukdar S., Olefsky J.M., Osborn O. Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases. Trends Pharmacol. Sci 2011, 32:543-550.
51. Tanaka N., Ishida T., Nagao M., Mori T., Monguchi T., Sasaki M., et al. Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanesepatients with dyslipidemia. Atherosclerosis 2014, 237:577-583.
52. Wilkinson S.E., Parker P.J., Nixon J.S. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem. J. 1993, 294(Pt 2):335-337.
53. Wortman P., Miyazaki Y., Kalupahana N.S., Kim S., Hansen-Petrik M., Saxton A.M., et al. n3 and n6 polyunsaturated fatty acids differentially modulate prostaglandin E secretion but not markers of lipogenesis in adipocytes. Nutr. Metab. (Lond) 2009, 6:5.
54. Wu Q., Wang H., Zhao X., Shi Y., Jin M., Wan B., et al. Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma. Oncogene 2013, 32:5541-5550.
55. Xu H.E., Lambert M.H., Montana V.G., Parks D.J., Blanchard S.G., Brown P.J., et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell 1999, 3:397-403.
56. Yeop Han C., Kargi A.Y., Omer M., Chan C.K., Wabitsch M., O'Brien K.D., et al. Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation. Diabetes 2010, 59:386-396.